The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach

Abstract The M1 family of metalloproteases represents a large number of exopeptidases that cleave single amino acid residues from the N-terminus of peptide substrates. One member of this family that has been well studied is aminopeptidase N (APN), a multifunctional protease known to cleave biologica...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shilvi Joshi, Lang Chen, Michael B. Winter, Yi-Lun Lin, Yang Yang, Mariya Shapovalova, Paige M. Smith, Chang Liu, Fang Li, Aaron M. LeBeau
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0da13595ddc84cff8dba8adb84bdbdf8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0da13595ddc84cff8dba8adb84bdbdf8
record_format dspace
spelling oai:doaj.org-article:0da13595ddc84cff8dba8adb84bdbdf82021-12-02T16:06:10ZThe Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach10.1038/s41598-017-01542-52045-2322https://doaj.org/article/0da13595ddc84cff8dba8adb84bdbdf82017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01542-5https://doaj.org/toc/2045-2322Abstract The M1 family of metalloproteases represents a large number of exopeptidases that cleave single amino acid residues from the N-terminus of peptide substrates. One member of this family that has been well studied is aminopeptidase N (APN), a multifunctional protease known to cleave biologically active peptides and aide in coronavirus entry. The proteolytic activity of APN promotes cancer angiogenesis and metastasis making it an important target for cancer therapy. To understand the substrate specificity of APN for the development of targeted inhibitors, we used a global substrate profiling method to determine the P1–P4′ amino acid preferences. The key structural features of the APN pharmacophore required for substrate recognition were elucidated by x-ray crystallography. By combining these substrate profiling and structural data, we were able to design a selective peptide inhibitor of APN that was an effective therapeutic both in vitro and in vivo against APN-expressing prostate cancer models.Shilvi JoshiLang ChenMichael B. WinterYi-Lun LinYang YangMariya ShapovalovaPaige M. SmithChang LiuFang LiAaron M. LeBeauNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shilvi Joshi
Lang Chen
Michael B. Winter
Yi-Lun Lin
Yang Yang
Mariya Shapovalova
Paige M. Smith
Chang Liu
Fang Li
Aaron M. LeBeau
The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
description Abstract The M1 family of metalloproteases represents a large number of exopeptidases that cleave single amino acid residues from the N-terminus of peptide substrates. One member of this family that has been well studied is aminopeptidase N (APN), a multifunctional protease known to cleave biologically active peptides and aide in coronavirus entry. The proteolytic activity of APN promotes cancer angiogenesis and metastasis making it an important target for cancer therapy. To understand the substrate specificity of APN for the development of targeted inhibitors, we used a global substrate profiling method to determine the P1–P4′ amino acid preferences. The key structural features of the APN pharmacophore required for substrate recognition were elucidated by x-ray crystallography. By combining these substrate profiling and structural data, we were able to design a selective peptide inhibitor of APN that was an effective therapeutic both in vitro and in vivo against APN-expressing prostate cancer models.
format article
author Shilvi Joshi
Lang Chen
Michael B. Winter
Yi-Lun Lin
Yang Yang
Mariya Shapovalova
Paige M. Smith
Chang Liu
Fang Li
Aaron M. LeBeau
author_facet Shilvi Joshi
Lang Chen
Michael B. Winter
Yi-Lun Lin
Yang Yang
Mariya Shapovalova
Paige M. Smith
Chang Liu
Fang Li
Aaron M. LeBeau
author_sort Shilvi Joshi
title The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
title_short The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
title_full The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
title_fullStr The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
title_full_unstemmed The Rational Design of Therapeutic Peptides for Aminopeptidase N using a Substrate-Based Approach
title_sort rational design of therapeutic peptides for aminopeptidase n using a substrate-based approach
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/0da13595ddc84cff8dba8adb84bdbdf8
work_keys_str_mv AT shilvijoshi therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT langchen therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT michaelbwinter therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT yilunlin therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT yangyang therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT mariyashapovalova therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT paigemsmith therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT changliu therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT fangli therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT aaronmlebeau therationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT shilvijoshi rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT langchen rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT michaelbwinter rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT yilunlin rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT yangyang rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT mariyashapovalova rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT paigemsmith rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT changliu rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT fangli rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
AT aaronmlebeau rationaldesignoftherapeuticpeptidesforaminopeptidasenusingasubstratebasedapproach
_version_ 1718385068535185408